Location:
Paul & Mildred Berg Hall, Li Ka Shing Center, Stanford
and virtual option
Photo credits: Siyeon Rhee, PhD
Welcome to 2024 Stanford Drug Discovery Symposium. This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.
— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
Participants
George Addona, PhD
Senior VP and Head of Discovery, Preclinical Development, and Translational Medicine, Merck
Carolyn Bertozzi, PhD
Baker Family Director of Stanford ChEM-H, Anne T. and Robert M. Bass Professor, Stanford University
Rob Califf, MD
Commissioner, U.S. Food and Drug Administration
Don Cleveland, PhD
Department Chair and Professor, Cellular and Molecular Medicine, University of California San Diego
Paulo Fontoura, MD, PhD
Global Head and SVP of Neuroscience, Immunology, Ophthalmology, and Rare Diseases, Roche
Karin Immergluck, PhD
Director, Stanford Office of Technology and Licensing
Michelle Longmire, MD
Chief Executive Officer, Co-Founder, Medable
Fady Malik, MD, PhD
Executive Vice President of Research & Development, Cytokinetics
Flavius Martin, MD
Executive Vice President of Research, Gilead Sciences
Yevgeniya Nusinovich, MD, PhD
Science Editor, Science Magazine
Camille Samuels, MBA
Partner, Venrock
Daniel Skovronsky, MD, PhD
CSO and Pres., Lilly Research Labs; Pres., Immunology, Eli Lilly and Company
Gregory Verdine, PhD
Erving Professor of Chemistry, Harvard University
Sharon Barr, PhD
Executive Vice President, BioPharmaceuticals R&D, AstraZeneca
Paul Biondi, MBA
Executive Partner and President of Pioneering Medicine, Flagship Pioneering
Rosa Canet-Avilés, PhD
Vice President, Scientific Programs & Education, California Institute for Regenerative Medicine
Marianne De Backer, MSc, PhD, MBA
Chief Executive Officer and Director, Vir Biotechnology
Julie Grant, MBA, MPhil
General Partner, Canaan Partners
Joe Jimenez, MBA
Co-Founder and Managing Director, Aditum Bio
Thomas Lynch, MD
President and Director, Fred Hutchinson Cancer Center
Mathai Mammen, MD, PhD
Chief Executive Officer, President, and Chairman, FogPharma
Lloyd Minor, MD
Carl and Elizabeth Naumann Professorship for the Dean, Stanford School of Medicine
Robert Plenge, MD, PhD
Executive Vice President, Chief Research Officer, Head of Research, Bristol Myers Squibb
Wade Shen
Director of Proactive Health Office, Advanced Research Projects Agency for Health
Andrew Trister, MD, PhD
Chief Medical Officer and Chief Scientific Officer, Verily Life Sciences
Michelle Williams, ScD
Joan and Julius Jacobson Professor of Epidemiology and Public Health, Harvard T.H. Chan School of Public Health
Hal Barron, MD
Chief Executive Officer and Founder, Altos Labs
Paul Burton, MD, PhD
Senior Vice President and Chief Medical Officer, Amgen
Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Research, Food and Drug Administration
Michael Devoy, MD
CMO and EVP of Medical Affairs and Pharmacovigilance for the Pharmaceuticals Division, Bayer
Aida Habtezion, MD
Chief Medical Officer and Head of Worldwide Medical and Safety, Pfizer
Hallie Kuhn, PhD
Senior Vice President, Alexandria Venture Investments
Grace Han McMahon
Associate Vice President, Pacific Business Development & Licensing, Merck
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research, Food and Drug Administration
Deep Nishar, MBA
Managing Director, General Catalyst
Joni Rutter, PhD
Director, National Center for Advancing Translational Sciences, National Institutes of Health
Abhishek Shukla
Managing Director, Prosperity7 Ventures
Andrea van Elsas, PhD
Partner, Third Rock Ventures
Bei Zhang, PhD
Corporate Vice President & TA Head, Diabetes, Obesity, & MASH (DO&M), Global Drug Discovery, Novo Nordisk
Lifetime Achievement Awardees
Catherine Boileau, PhD, PharmD
Emeritus Professor of Genetics, Medical School of Paris Cité University, Inserm UMR1148 LVTS Research Center, Bichat University Hospital
Helen Hobbs, MD
Philip O'Bryan Montgomery Jr., MD, Distinguished Chair in Developmental Biology
Eugene McDermott Distinguished Chair for the Study of Human Growth and Development
UT Southwestern Medical Center
Event Program & Poster
FAQs
Foundation Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Media Partners
Organizers
Amanda Chase, PhD
Associate Director of Strategic Research Development
Stanford Cardiovascular Institute
Kuldev Singh, MD
Professor of Ophthalmology
Stanford University School of Medicine
Sanjay Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU
Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine
Mark Mercola, PhD
Professor of Medicine
Stanford University School of Medicine
Francesca Mae G. Tongco, MS-HCA
Project Coordinator
Stanford Cardiovascular Institute
For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.